Holen Sie sich die Stockscreener-App
156.45
3.84%
5.79
Handel nachbörslich:
156.73
0.28
+0.18%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Merck Co Inc Aktie (MRK) Neueste Nachrichten
The Goldman Sachs Group Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Strong Merck stock trades close to its 52-week high as analysts lift targets after melanoma trial wi - Ad-hoc-news.de
Merck & Co Inc Stock (MRK) Moved Up by 3.41% on Aug 21: Facts Behind the Movement - TradingKey
Moderna and Merck cancer vaccine success paves way for future - EMJ
TCW Group Inc. Sells 16,921 Shares of Merck & Co., Inc. $MRK - MarketBeat
Summit Global Investments Sells 15,559 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Commonwealth Retirement Investments LLC - MarketBeat
Crew Capital Management Ltd Acquires 7,742 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Acumen Wealth Advisors LLC - MarketBeat
RBC Capital Downgrades Merck & Co as Profit-Taking Sets In - marketscreener.com
Merck & Co. stock hits record high as cancer vaccine data lifts 2026 outlook - Ad-hoc-news.de
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $170.00 - MarketBeat
Merck Raises the Stakes for Pfizer's Cancer Vaccine AmbitionsModerna (NASDAQ:MRNA), Merck & Co (NYSE:M - Benzinga
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $175.00 - MarketBeat
Merck & Co. stock extends double-digit August rally as analyst calls and cancer vaccine data reshape - Ad-hoc-news.de
RBC Capital downgrades Merck & Co as profit-taking hits the stock - marketscreener.com
Merck upgraded at Morgan Stanley after cancer trial win; RBC downgrades - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Downgraded to "Sector Perform" Rating by Royal Bank Of Canada - MarketBeat
This Merck Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Elon Musk Backs mRNA As Moderna's Stock Soars on Cancer Vaccine WinModerna (NASDAQ:MRNA) - Benzinga
Merck & Co., Inc. (NYSE:MRK) Raised to Overweight at Morgan Stanley - MarketBeat
Goldman Sachs Adjusts Price Target on Merck & Co. to $160 From $140, Keeps Buy Rating - Moomoo
Merck & Co., Inc. (NYSE:MRK) Stock Rating Lowered by Jefferies Financial Group - MarketBeat
Morgan Stanley Upgrades Merck & Co. to Overweight From Equalweight, Adjusts PT to $179 From $116 - marketscreener.com
Jennison Associates LLC Has $350.67 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Trimmed by Hohimer Wealth Management LLC - MarketBeat
Hodges Capital Management Inc. Sells 8,148 Shares of Merck & Co., Inc. $MRK - MarketBeat
Massachusetts Financial Services Co. MA Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. stock jumps to record high as cancer vaccine data eases Keytruda risk - Ad-hoc-news.de
MERCK & CO INC : JEFFERIES RAISES TARGET PRICE TO $175 FROM $152 - Moomoo
Why Did MRNA, MRK, TGT Stocks Jump To 52-Week Highs Today? - TradingView
Healthcare Stocks After Hours: Moderna, Merck Cool Following Cancer Trial GainsPfizer (NYSE:PFE), Mode - Benzinga
Merck & Co Inc : Argus Research Raises Ta - Moomoo
MRNA, BULL, BMNR, MSTR, MRK: 5 Trending Stocks TodayModerna (NASDAQ:MRNA) - Benzinga
Shareholders that lost money on Merck & Co., Inc.(MRK) should con - The National Law Review
Why Moderna Stock Skyrocketed Today - The Motley Fool
Moderna and Merck: Intismeran's Positive Phase 3 Readout Confirms mRNA Potential in Oncology - Morningstar
Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy? - Finviz
Merck, Moderna Cancer Vaccine Breakthrough Puts 4 ETFs In FocusMerck & Co (NYSE:MRK) - Benzinga
Merck & Co Inc (MRK) Stock Up 12.6% but GF Value Says Overvalued -- GF Score: 72/100 - GuruFocus
Merck's Large Late-Stage Pipeline Is Building Solid Defense Against Keytruda's Patent Cliff - Morningstar
Pfizer Stock Rises Wednesday: What's Going On? - Benzinga
Stock Traders Buy High Volume of Merck & Co., Inc. Call Options (NYSE:MRK) - MarketBeat
Huge Unusual Put Options Volume in MerckIs MRK Stock Overvalued? - Barchart.com
MERCK CO INC - Financial Post
Merck Soars On Cancer Vaccine Trial Win With Moderna, More Upside Ahead (NYSE:MRK) - Seeking Alpha
Merck: Why Consolidation Looks Like The Next Move (Rating Downgrade) (NYSE:MRK) - Seeking Alpha
Merck stock hits a new 52-week high on melanoma data - Ad-hoc-news.de
Moderna's Cancer Vaccine Win Is Merck's Story Too - Benzinga
Tempus AI Soars as Merck-Moderna Cancer Trial Validates Personalis Acquisition - Benzinga
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results - Reuters
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday - Benzinga
Merck & Co Inc Stock (MRK) Opened Up by 8.82% on Aug 19: Key Drivers Unveiled - tradingkey.com
Moderna, Merck surge on positive trial results for melanoma vaccine - Sharecast.com
Merck and Moderna Release Landmark Personalized Cancer Therapy Trial Success, Stocks Soar - Benzinga
Merck, Moderna say melanoma vaccine meets goals in large trial - Reuters
Narwhal Capital Management Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Vest Financial LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by D.A. Davidson & CO. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Sets New 12-Month HighHere's What Happened - MarketBeat
Benjamin Edwards Inc. Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck stock holds firm as Q2 sales hit $16.61 billion - AD HOC NEWS
Merck stock hits a record high. Investors track valuation and growth - AD HOC NEWS
Cisco, Merck, Cheniere Energy And More: CNBC’s ‘Final Trades’ - Benzinga
Merck & Co. Inc. Invests $9.04 Billion in Sutro Biopharma, Inc. $STRO - MarketBeat
Merck & Co. Inc. Takes Position in Kymera Therapeutics, Inc. $KYMR - MarketBeat
93,414 Shares in Viridian Therapeutics, Inc. $VRDN Purchased by Merck & Co. Inc. - MarketBeat
What Is Driving Interest in Merck & Co. (NYSE:MRK) as Pharmaceutical Deals Keep Flowing? - Kalkine Media
Munich Reinsurance Co Stock Corp in Munich Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
Mizuho Markets Cayman LP Invests $960,000 in Merck & Co., Inc. $MRK - MarketBeat
Resilient Merck stock holds close to a 12-month high on oncology strength - AD HOC NEWS
Merck (NYSE: MRK): What Could Drive Its Next Phase? - Kalkine Media
Resilient Merck stock trades at a 12-month high as fresh FDA approvals and Q2 2026 growth support th - AD HOC NEWS
Merck & Company, Inc. (MRK) Investor Outlook: Exploring Growth with a Robust Pipeline and Strategic Collaborations - DirectorsTalk Interviews
Merck & Co., Inc. (NYSE:MRK) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
ABN Amro Investment Solutions Has $39.71 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck stock trades close to its 12-month high as Q2 2026 growth and Keytruda momentum support the ou - AD HOC NEWS
1.24%
0.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):